Calcium electrotransfer for termination of transgene expression in muscle

Human Gene Therapy

Volumn 22, Issue 6, 2011, Pages 753-760

  Hojman, Pernille ^a,b   Spanggaard, Iben ^a   Olsen, Caroline Holkman ^a   Gehl, Julie ^a   Gissel, Hanne ^c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEMOGLOBIN ANALYSIS; HISTOPATHOLOGY; IN VIVO STUDY; MOUSE; MUSCLE TISSUE; NONHUMAN; RAT; TIBIA;

ANIMALS; CALCIUM; ELECTROPORATION; ERYTHROPOIETIN; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; MICE; MICE, INBRED C57BL; MUSCLES; RATS; RATS, WISTAR; TRANSGENES;

RATTUS;

EID: 79958219661     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2010.209     Document Type: Article

References (41)

1. Aihara, H., and Miyazaki, J. (1998). Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867-870. (Pubitemid 28405859)
2. Andre, F., Gehl, J., Sersa, G., et al. (2008). Efficiency of high and low voltage pulse combinations for gene electrotransfer in muscle, liver, tumor and skin. Hum. Gene Ther. 19, 1261-1271.
3. Bainbridge, J., Smith, A.J., Barker, S.S., et al. (2008). Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 358, 2231-2239. (Pubitemid 351724452)
4. Berchtold, M.W., Brinkmeier, H., and Muntener, M. (2010). Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol. Rev. 80, 1215-1265.
5. Bettan, M., Emmanuel, F., Darteil, R., et al. (2000). High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol. Ther. 2, 204-210.
6. Bier, M., Hammer, S.M., Canaday, D.J., and Lee, R.C. (1999). Kinetics of sealing for transient electropores in isolated mammalian skeletal muscle cells. Bioelectromagnetics 20, 194-201. (Pubitemid 129548206)
7. Cerella, C., Diederich, M., and Ghibelli, L. (2010). The dual role of calcium as messenger and stressor in cell damage, death, and survival. Int. J. Cell Biol. 2010:546163.
8. Clark, K.M., Bindoff, L.A., Lighttowlers, R.N., et al. (1997). Reversal of a mitochondrial, DNA defect in human skeletal muscle. Nat. Genet. 16, 222-224.
9. Daud, A.I., DeConti, R.C., Andrews, S., et al. (2008). Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma. J. Clin. Oncol. 26, 5896-5903.
10. Draghia-Akli, R., Ellis, K.M., Hill, L.A., et al. (2003). High-efficiency growth hormone-releasing hormone plasmid vector administration into skeletal muscle mediated by electropora-tion in pigs. FASEB J. 17, 526-528.
11. Fattori, E., Cappelletti, M., Zampaglione, I., et al. (2005). Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates. J. Gene Med. 7, 228-236. (Pubitemid 40348027)
12. Favard, C., Dean, D.S., and Rols, M.P. (2007). Electrotransfer as a non viral method of gene delivery. Curr. Gene Ther. 7, 67-77. (Pubitemid 46322289)
13. Gehl, J. (2003). Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand. 177, 437-447. (Pubitemid 36411581)
14. Gehl, J., Skovsgaard, T., and Mir, L.M. (2002). Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim. Biophys. Acta 1569, 51-58. (Pubitemid 34165557)
15. Gissel, H. (2010). Effects of varying pulse parameters on ion homeostasis, cellular integrity, and force following electro-poration of rat muscle in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298:R918-R929.
16. Goll, D.E., Thompson, V.F., Li, H., et al. (2010). The calpain system. Physiol. Rev. 83, 731-801.
17. Gossen, M., Freundlieb, S., Bender, G., et al. (1995). Transcrip-tional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
18. Gothelf, A., Eriksen, J., Hojman, P., and Gehl, J. (2010). Duration and level of transgene expression after gene electrotransfer to skin in mice. Gene Ther. 17, 839-845.
19. Gothelf, A., Hojman, P., and Gehl, J. (2009). Change in hemoglobin levels due to anesthesia in mice: an important con-founder in studies on hematopoietic drugs. Biol. Proc. Online 11, 325-330.
20. Gothelf, A., Mir, L.M., and Gehl, J. (2003). Electrochemotherapy: results of cancer treatment using enhanced delivery of bleo-mycin by electroporation. Cancer Treat. Rev. 29, 371-387. (Pubitemid 37185104)
21. Heller, L.C., and Heller, R. (2006). In vivo electroporation for gene therapy. Hum. Gene Ther. 17, 890-897. (Pubitemid 46076749)
22. Heller, R., Jaroszeski, M.J., Reintgen, D.S., et al. (1998). Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 83, 148-157. (Pubitemid 28299641)
23. Hojman, P. (2010). Basic principles and clinical advancements of muscle electrotransfer. Curr. Gene Ther. 10:128-138.
24. Hojman, P., Eriksen, J., and Gehl, J. (2007a). Tet-On induction with doxycycline after gene transfer in mice: sweetening of drinking water is not a good idea. Anim. Biotechnol. 18, 183-188. (Pubitemid 47147859)
25. Hojman, P., Eriksen, J., and Gehl, J. (2009). In vivo imaging of far-red fluorescent proteins after, DNA electrotransfer to muscle tissue. Biol. Prod. Online 11, 253-262.
26. Hojman, P., Gissel, H., Andre, F., et al. (2008). Physiological effects of high and low voltage pulse combinations for gene electrotransfer in muscle. Hum. Gene Ther. 19, 1249-1261.
27. Hojman, P., Gissel, H., and Gehl, J. (2007b). Sensitive and precise regulation of haemoglobin after gene transfer of erythropoie-tin to muscle tissue using electroporation. Gene Ther. 14, 950-959. (Pubitemid 46865506)
28. Hojman, P., Zibert, J., Gissel, H., et al. (2007c). Gene expression profiles in skeletal muscle after gene electrotransfer. BMC Mol. Biol. 8:56.
29. Kohn, D. (2010). Update on gene therapy for immunodeficiencies. Clin. Immunol. 135, 247-254.
30. Lu, Q.L., Bou-Gharios, G., and Partridge, T.A. (2003). Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther. 10, 131-142. (Pubitemid 36582585)
31. Lucas, M.L., and Heller, R. (2001). Immunomodulation by electrically enhanced delivery of plasmid, DNA encoding, IL-12 to murine skeletal muscle. Mol. Ther. 3, 47-53. (Pubitemid 32509804)
32. Maguire, A.M., Simonelli, F., Pierce, E.A., et al. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358, 2240-2248. (Pubitemid 351724453)
33. Marty, M., Sersa, G., Garbay, J.R., et al. (2006). Electro-chemotherapy- an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electro-chemotherapy) study. Eur. J. Cancer Suppl. 4, 3-13. (Pubitemid 44755131)
34. Mathiesen, I. (1999). Electropermeabilisation of skeletal muscle enhances gene transfer in vivo. Gene Ther. 6, 508-514. (Pubitemid 29192659)
35. Mir, L.M., Bureau, M.F., Gehl, J., et al. (1999). High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. U. S. A. 96, 4262-4267. (Pubitemid 29190324)
36. TM by means of invasive or non-invasive electrodes. Eur. J. Cancer Suppl. 4, 14-25. (Pubitemid 44755132)
37. Nethery, D., Callahan, L.A., Stofan, D., et al. (2000). PLA2 dependence of diaphragm mitochondrial formation of reactive oxygen species. J. Appl. Physiol. 89, 72-80. (Pubitemid 30482565)
38. Nordstrom, J.N. (2003). The antiprogestin-dependent GeneS-witch® system for regulated gene therapy. Steroids 68, 1085-1094.
39. Sallberg, M., Frelin, L., Diepolder, H.M., et al. (2009). Activation of T cell responses and reductions in the viral load following therapeutic vaccination using naked DNA delivered by in vivo electroporation in patients with chronic hepatitis C. [Abstract.] Mol. Ther. 17(1), S15.
40. Sandercock, D.A., and Mitchell, M.A. (2010). Myopathy in broiler chickens: a role for Ca(2+)-activated phospholipase A2? Poult. Sci. 82, 1307-1312.
41. Shcherbo, D., Merzlyak, E.M., Chepurnykh, T.V., et al. (2007). Bright far-red fluorescent protein for whole-body imaging. Nat. Methods 4, 741-746. (Pubitemid 47338169)